Clifton Park, NY, United States of America

Kurt A Josef

USPTO Granted Patents = 28 

 

Average Co-Inventor Count = 5.9

ph-index = 6

Forward Citations = 88(Granted Patents)


Location History:

  • Clifton Park, PA (US) (1994 - 1995)
  • Clifton Park, NY (US) (1994 - 1997)
  • Wayne, PA (US) (1995 - 1997)
  • Wilmington, DE (US) (2000 - 2006)
  • Radnor, PA (US) (2012 - 2017)
  • San Diego, CA (US) (2018)

Company Filing History:


Years Active: 1994-2018

Loading Chart...
Loading Chart...
28 patents (USPTO):

Sure, here is the article about inventor Kurt A Josef:

Title: The Innovations of Kurt A Josef: A Pioneer in Pharmaceutical Research

Introduction:

Kurt A Josef, a distinguished inventor based in Clifton Park, NY, has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions. With a total of 28 patents to his name, Josef is recognized for his innovative approach to drug development.

Latest Patents:

Among his latest patents is the creation of Uracil derivatives as AXL and c-MET kinase inhibitors. These compounds, formulated according to Formula I or its salt forms, demonstrate promising potential in the treatment of various medical conditions. Josef's inventions not only focus on novel compounds but also encompass methods of treatment and application in the pharmaceutical industry.

Career Highlights:

Throughout his career, Kurt A Josef has worked with reputable companies such as Sterling Winthrop Inc. and Cephalon, Inc. These collaborations have provided Josef with the platform to further his research and bring his inventions to fruition. His expertise and dedication have led to the successful development of groundbreaking pharmaceutical products.

Collaborations:

Josef's innovative work has been supported by talented individuals within the industry, including Edward R Bacon and Carl R Illig. Collaborating with like-minded professionals has enabled Josef to exchange ideas, refine his inventions, and ultimately contribute to the advancement of pharmaceutical science.

Conclusion:

In conclusion, Kurt A Josef stands as a pioneering figure in the realm of pharmaceutical innovations. His numerous patents, including the recent Uracil derivatives, reflect his commitment to pushing the boundaries of drug development. Through his collaborations with industry experts and his tenure at esteemed companies, Josef continues to shape the landscape of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…